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Background. An emerging MRI reporter, ferritin heavy chain (FTH1), is recently applied to enhance the contrast and increase
the sensitivity of MRI in the monitoring of solid tumors. However, FTH1-overexpression-related cytotoxicity is required to
be explored. Methods. By using the Tet-Oﬀ system, FTH1 overexpression was semi-quantitativiely and dynamicly regulated by
doxycycline in a NPC cell line. Eﬀects of FTH1 overexpression on the proliferation, cytotoxicity, apoptosis and migration of
NPC cells were investigated in vitro, and MR relaxation rate was measured in vitro and in vivo. Results. In vitro and in vivo
overexpressionofFTH1signiﬁcantlyincreasedthetransverserelaxivity(R2),whichcouldbeenhancedbyironsupplementation.In
vitro, overexpression of FTH1 reduced cell growth and migration, which were not reduced by iron supplementation. Furthermore,
cells were subcutaneously inoculated into the nude mice. Results showed FTH1 overexpression decreased tumor growth in the
absence of iron supplementation but not in the presence of iron supplementation. Conclusion. To maximize R2 and minimize
the potential adverse eﬀects, supplementation of iron at appropriate dose is recommended during the application of FTH1 as a
reporter gene in the monitoring of NPC by MRI.
1.Background
Magnetic resonance imaging (MRI) is widely used in the
diagnosis, staging, followup, and prediction of diseases in
clinical practice [1–4]. In the biological research, MRI
has been applied to monitor the growth of solid tumors,
gene expression, angiogenesis, and apoptosis in various
animal models [5–8]. MRI allows views into opaque subjects
and provides soft-tissue contrast at reasonably high spatial
resolution. However, the low sensitivity and speciﬁcity of
MRI signiﬁcantly limited its wide application.
It has been reported that ferritin gene, an emerging MRI
reporter gene, can enhance the contrast and increase the
sensitivity of MRI [9–11]. In vertebrates, ferritin is a het-
eropolymer composed of variable proportions of heavy and
light chains. Twenty-four heavy and light chains assemble to
form a ferritin molecule. The ferritin heavy chain (FTH1) is
the major regulator of ferritin activity. FTH1 has ferroxidase
activity promoting the iron oxidation and incorporation.
In contrast, the light chain lacks the detectable ferroxidase
activity but increases the activity of FTH1 [12]. Unlike
superparamagnetic iron oxide particles (SPIOs) and other
particle-based techniques [13, 14], the genetic modiﬁed
transgene of FTH1, like other MR reporters, [15, 16]
would not be diluted when cells divide. In this regard, the
continuous production of FTH1 in the daughter cells oﬀers a
signiﬁcantadvantageforcelltrackingbyMRIoveraparticle-
based cell labeling method. So far, a few studies have focused
on FTH1 as an emerging reporter, in which overexpression
of FTH1 can alter the MR signal in its expression site and2 Journal of Biomedicine and Biotechnology
yield robust image contrast [9, 10, 15–21]. However, no
studies have tested the role of FTH1 in the nasopharyngeal
carcinoma (NPC) cells.
The results on the FTH1 as a safe MRI reporter were
inconsistent in previous studies. Cozzi et al. [22]d e m o n -
strated that overexpression of FTH1 in the Hela cells induced
an iron-deﬁcient phenotype with signiﬁcantly reduced cell
growth, which could be reversed by incubation in the iron-
containing medium. Overexpression of FTH1 in the C6
gliomacells[9]andstemcells[17]didnotreducecellgrowth
evenintheabsenceofironsupplementation.However,Liuet
al. [16] described in the discussion section (data not shown)
of their paper that signiﬁcant reduction of growth rate was
observed in the C6 glioma cells in the presence of high FTH1
transgene expression. Based on these ﬁndings, the present
study aimed to investigate the potential adverse eﬀects of
FTH1 on NPC cells.
NPC is a nonlymphomatous squamous cell carcinoma
arising from the mucosal epithelium of the nasopharynx.
NPC is common in southern regions of China, Northern
Africa, and Alaska [23] .T h ep o o rs u r v i v a lr a t ea n dh i g h
recurrence prompt us to ﬁnd new therapeutic approaches
for this disease. However, the development of treatment for
NPChasbeenhamperedduetolackofconventionalcellsand
animal models for the eﬀective, noninvasive, spatiotemporal,
and real-time monitoring of therapeutic eﬃcacy. In the
present study, the NPC cell model was employed.
In our study, FTH1 overexpression was semiquantita-
tively controlled by using doxycycline in the Tet-Oﬀ system
aiming to investigate the therapeutic eﬀect of FTH1 and
furtherassessthepotentialadverseeﬀectsofFTH1asanMRI
reporter in NPC cells.
2. Methods
2.1. Construction of Plasmids and Reverse Transcription PCR
(RT-PCR). The open reading frame (ORF) of human FTH1
gene with Kozak sequence was ampliﬁed by RT-PCR from
the total RNA of S18 cells and then subcloned into the SmaI
site of pUC119 to yield pUC119-FTH1. After sequencing,
the fragment released by BglII and EcoRI from pUC119-
FTH1 was cloned into the same site of pTRE-Tight-BI-
Luc (Clontech Laboratories, Inc., Palo Alto, CA) to yield
pTRE-Tight-BI-Luc-FTH1. For RT-PCR, the ﬁrst strand
cDNA was reversely transcribed with oligo (dT) primer. The
full-length FTH1 gene with Kozak sequence was ampliﬁed
using PrimeSTAR HS DNA Polymerase (TaKaRa, Dalian,
China). The sense primer was 5 -GAATTCGCCACCATG-
ACGACCGCGTCCACCTC-3  and the antisense primer 5 -
AGATCTGGTACCTTTAGCTTTCATTATCACTGTC-3 .
2.2. Cell Culture. NPC S18 cells (kindly gifted by Dr. Chao-
nan Qian) [24] were grown in Dulbecco’s Modiﬁed Eagle’s
Medium (DMEM)—high glucose (GIBCO, Grand Island,
N.Y.) containing 10% fetal bovine serum (FBS; Clontech
Laboratories, Inc., Palo Alto, CA). The parent cells, which
were developed by stably transfecting pTet-Oﬀ Advanced
vector into S18 cells, were grown in complete DMEM
containing 100μg/mL G418 (Clontech Laboratories, Inc.,
Palo Alto, CA). The double-stable cell line (B-7) was
grown in complete DMEM containing 100μg/mL G418 and
100μg/mLhygromycin(AlexisBiochemicals,SanDiego,CA)
with or without 10ng/mL doxycycline (Alexis Biochemicals,
San Diego, CA). In the experiments with iron supplemen-
tation, ferric ammonium citrate at diﬀerent concentrations
(FAC; Sigma-Aldrich Biotechnology, St. Louis, MO) was
added to the medium.
2.3.TransfectionProtocolandGenerationofStableCellClones.
Cells were transfected using Lipofectamine2000 (Invitrogen,
Carlsbad, CA) according to the manufacturer’s instructions.
The NPC S18 cells were ﬁrst transfected with pTet-Oﬀ
Advanced vector and screened in complete medium contain-
ing 500μg/mL G418. The screened clones (parent cell) were
then transfected with pTRE-Tight-BI-Luc-FTH1. These cells
werescreenedinthepresenceof500μg/mLG418,250μg/mL
hygromycin, and 10ng/mL doxycycline. The well-grown
clones were subjected to screening of expression of luciferase
andFTH1.Severaldouble-stablecloneswereselectedandthe
B-7 clone was used in the following experiments.
2.4. Detection of Luciferase Activity. Cells (1 × 104/well) were
plated into 96-well plates, grown for 48h, and washed twice
with phosphate-buﬀered saline (PBS). The cells were lysed,
and then assayed for the luciferase activity with the luciferase
assay system, in accordance with the manufacturer’s instruc-
tions (Promega, Madisson, WI, USA). The luciferase activity
was measured with the GloMax 96 Microplate Luminometer
(Promega,Madisson,WI,USA)usingstandardprotocol.The
luminescence results were reported as arbitrary light units
that were measured in 10 seconds per sample. To measure
the luciferase activity in vivo, mice were anesthetized and
D-luciferin solution (Promega, Madisson, WI, USA) was
intraperitoneally injected at 125mg/kg body weight 10min
prior to imaging. A gray-scale body-surface reference image
was obtained using the NightOWL LB 981 NC 100 CCD
camera (Berthold, Wildbad, Germany). Photons emitted
from the luciferase of animals and transmitted through the
tissues were collected and integrated for a 5-minute period.
The signal intensities from manually derived regions of
interest (ROI) were obtained and data expressed as photon
ﬂux (photons/sec). Background photon ﬂux was deﬁned
from an ROI of same size being placed in a nonluminescent
area nearby the animal and then subtracted from the
measured luminescent signal intensity (SI).
2.5.WesternBlotandImmunohistochemistry. Cellswerelysed
in RIPA buﬀer. Total protein concentration was determined
by bicinchoninic acid (BCA) method. Then, 25μgo ft o t a l
proteins were subjected to 12% SDS-PAGE and transferred
onto polyvinylidene ﬂuoride (PVDF) membranes which
were then blocked in 5% nonfat milk in TBST (20mM
Tris PH 7.6, 137mM NaCL, 0.1% Tween20). Subsequently,
these membranes were incubated with primary antibod-
ies overnight at 4◦C (rabbit anti-FTH1 1:1000 (Santa
Cruz Biotechnology, California, USA), rabbit anti-GAPDHJournal of Biomedicine and Biotechnology 3
1:2000 (GenScript, Nanjing, China)). After washing several
times, the membranes were treated with secondary antibod-
ies (HRP-conjugated goat anti-rabbit 1:5,000 (Invitrogen,
Carlsbad, CA)), and visualized using the enhanced chemi-
luminescence kit.
FTH1 expression in the xenografted tumors was detected
by immunohistochemistry. At the end of 3 weeks, mice were
sacriﬁcedandthexenograftedtumorswerecutinto4μmsec-
tions. Following treatment with anti-FTH1 antibody, these
sections were treated with biotinylated anti-rabbit secondary
antibody and then ABC reagent (Invitrogen, Carlsbad, CA),
and visualized using diaminobenzidine (DAB).
2.6. Determination of Iron Content. Inductively coupled
plasma mass spectrometry (ICP-MS) was employed to
qualitatively determine the iron content in cells and tumors
(cells:106 cells/sample;tumors:Fecontentnormalizedbythe
dry weight).
2.7.DetectionofCell Proliferation,Cytotoxicity, andApoptosis.
The cell proliferation kit I (MTT-based) was used to detect
thecellproliferationaccordingtothemanufacturer’sinstruc-
tions (Roche Diagnostics, Mannheim, Germany). Cytotox-
icity was measured by detecting the amount of enzyme
glucose-6-phosphate dehydrogenase (G6PD) released into
the medium according to the manufacturer’s instructions
(Invitrogen, Carlsbad, CA). For apoptosis assay, Hoescht
staining was used according to vendor protocol (Promega,
Madisson, WI, USA).
2.8. Migration Assay. Migration assay was performed using
the 24-well transwell inserted with a polycarbonate mem-
brane (6.5mm in diameter, 8.0μm in pore size, Costar).
The lower chamber was ﬁlled with standard medium. The
upper chamber was seeded with 2 × 104 B-7 cells/well in
conditional medium with or without 200μMF A C .C e l l s
were allowed to migrate for 24h at 37◦C and then stained
in PBS containing 50μg/mL propidium iodide. Cells on
the upper surface of the membrane were removed with a
cell scraper and migrated cells on the lower surface ﬁxed
in 4% paraformaldehyde and counted. The proportion of
migrating B-7 cells in the standard medium served as a
control and were deﬁned as 100%. The proportion of
migrating B-7 cells in other conditions was calculated as the
percentage of control value.
2.9. MRI In Vitro. Cells were thoroughly washed to remove
free iron and dissociated with trypsin, followed by ﬁxation
in 4% paraformaldehyde for 10min. The cells in 96-well
plate (5 × 107 cells/well) were centrifuged at 1000rpm for
5min (Beckman, CA, USA) and supernatant was removed.
Then, 100μL of 1% agarose in PBS were added to the cell
pellet which remained as pellet in the agarose. Transverse
relaxation rate (R2, R2 = 1/T2) was determined from spin-
echo image at GE Signa 1.5 T MR Scanner (multiecho spin
echo; TR: 4000ms; seven echo times: 40, 80, 120, 200, 240,
280 and 320ms; matrix: 128 × 128; FOV: 40 × 40mm).
A horizontal slice was selected using orthogonal images,
through the center of cell pellet of all wells (2mm in slice
thickness). ROIs of each cell pellet were drawn manually in
a slice through the center of cell pellet, and the mean SI
was measured using the software for system. The natural
logarithm of SI was plotted as a function of TE, and the
R2 value was calculated as the negative of the slope of
a regression line ﬁt to the data (Excel, Microsoft Inc.).
These measurements were repeated in triplicates and data
presented as mean ± standard deviation (SD). Data were
analyzed with the two-tailed unpaired Student’s t-test.
2.10. MRI In Vivo. All mice used in these experiments
were maintained under the protocols approved by the
Institutional Animal Care and Use Committee of Sun
Yat-sen University. Cells were subcutaneously inoculated
(106 cells/mouse) into hind ﬂank of BALB/c-nude mice
(females, 6–10 weeks, 28–30g). At the indicated time points,
MRI was performed using a Siemens 3.0 T Trio MR scanner
(TE: 40ms, TR: 6000ms, FOV: 60 × 60mm, matrix: 300
× 300, slice thickness: 2mm). T2 and R2 were calculated
by ﬁtting decay curves delineated from a Carr-Purcell-
Meiboom-Gill (CPMG) sequence. Changes in the relaxation
rate were determined by selection of an ROI (for tumors
or cell pellets) on the relaxation maps. Data were expressed
as mean ± SD and analyzed with the two-tailed unpaired
Student’s t-test.
Tumor volumes were calculated based on the MR images
at the end of 1, 2, and 3 weeks according to the following
formula:volume=width2×length ×0.52[25]intheabsence
of iron supplementation.
3. Results
3.1. Overexpression of FTH1 in NPC S18 Cells. Tet-Oﬀ
Advanced system was used to generate a cell model with
controlled gene expression [26]. NPC S18 cells were stably
transfected with pTet-Oﬀ Advanced vector and the clones
expressing doxycycline-dependent regulator were selected
and used as parent cells. FTH1 was cloned into the pTRE-
Tight-BI-Luc vector and under the control of inducible
doxycycline responsive promoter (Figure 1(a)). The resulted
vectors, which could simultaneously express luciferase and
FTH1 under the control of same promoter, were used to
transfect the parent cells. Among the stable transfectant
clones, one was selected and named as B-7. B-7 cells
were grown in the presence (Dox+) or absence (Dox−)o f
10ng/mL doxycycline for 48h, to test whether luciferase
activity could be induced by doxycycline. As shown in
Figure 1(b), luciferase activity of B-7 cells in the absence
of doxycycline was 3000-fold higher than that in the
presence of doxycycline. Additionally, B-7 cells in presence of
doxycyclineweretransferredtomediumwithoutdoxycycline
and grown for diﬀerent durations. The time-dependent
expression of FTH1 was determined by Western blot assay.
Results showed the FTH1 level increased gradually within
72h and then remained stable (Figure 1(c)). Furthermore,
B-7 cells were grown in medium containing doxycycline4 Journal of Biomedicine and Biotechnology
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Figure 1: Doxycycline-regulated expression of luciferase and FTH1
in NPC S18 cells. (a) The schematic for the preparation of
pTRE-Tight-BI-Luc-FTH1 used to generate the double-stable cell
line, B-7, which could inducibly express luciferase and FTH1
simultaneously under the control of same promoter. (b) Luciferase
activity induced by doxycycline. B-7 cells were grown in presence
(Dox+) or absence (Dox−) of 10ng/mL doxycycline for 48h. Cells
were analyzed for luciferase activity. Data were expressed as mean ±
SD from 3 experiments. (c) Time-dependent FTH1 expression. B-7
cells grown in Dox containing medium were transferred to medium
without Dox and grown for diﬀerent durations. (d) Doxycycline
dose-dependent FTH1 expression. B-7 cells were grown in medium
containing doxycycline at diﬀerent concentrations for 96h. FTH1
was determined by Western blot assay. Dox, doxycycline.
at diﬀerent concentrations for 96h to determine the dose-
dependent expression of FTH1. FTH1 expression was
maximally inhibited when the doxycycline concentration
was ≥10ng/mL and increased to a moderate level when the
doxycycline was 0.1ng/mL. It was completely derepressed
when doxycycline was absent (Figure 1(d)). In the repressed
07 2 Dox−(hours)
TfR-1
GAPDH
(a)
20
15
10
5
0
10 50 100 200 500 1000
I
r
o
n
 
u
p
t
a
k
e
 
(
n
g
/
1
0
6
c
e
l
l
s
)
Dox+
Dox−
0
Concentrations of FAC (µM)
(b)
20
15
10
5
0
10 0.1 0
Concentrations of Dox (ng/mL)
I
r
o
n
 
u
p
t
a
k
e
 
(
n
g
/
1
0
6
c
e
l
l
s
)
FAC−
FAC+
(c)
Figure 2: Overexpression of FTH1 led to increase of both transfer-
rin receptor 1 (TfR-1) and intracellular iron content. (a) Western
blot assay of TfR-1 expression induced by FTH1. B-7 cells grown
in the presence of doxycycline (10ng/mL) (Dox+) were transferred
to Fe containing medium (200μM FAC) in absence of doxycycline
(Dox−) followed by incubation for 72h. (b, c) Quantiﬁcation of
intracellular iron content by ICP-MS. (b) B-7 cells were grown in
t h ep r e s e n c e( D o x + )o ra b s e n c e( D o x −) of doxycycline (10ng/mL)
in the presence of FAC at diﬀerent concentrations for 48h, (c) B-7
cells grown in the presence of doxycycline at various concentrations
were incubated with (FAC+) or without (FAC−) (200μM) for 48h.
Data were expressed as mean ± S Df r o m3e x p e r i m e n t s .F A C ,f e r r i c
ammonium citrate. ICP-MS, inductively coupled plasma atomic
emission spectrometry.Journal of Biomedicine and Biotechnology 5
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Figure 3: Eﬀects of FTH1 overexpression on cell proliferation, cytotoxicity, apoptosis, and migration. (a) High expression of FTH1 reduced
cell growth without iron supplementation while did not reduce cell growth with iron supplementation. MTT assay was used to assess the
eﬀect of FTH1 overexpression on the cell proliferation. (b) FTH1 overexpression did not increase the release of G6PD regardless of Fe
supplementation. High G6PD release represents increased toxicity. (c) FTH1 overexpression did not increase the cell apoptosis by hoechst
apoptosisassayregardlessofironsupplementation.(d)HighexpressionofFTH1reducedcellmigrationwithoutironsupplementationwhile
did not reduce cell migration with iron supplementation. Data were normalized by those in B-7 cells in 10ng/mL Dox which was deﬁned as
100%; G6PD, glucose-6-phosphate dehydrogenase. Data were expressed as mean ± SD from 6 experiments. (∗P<0.05: two-tailed unpaired
t-test.)
state, slightly higher FTH1 level than that in the parent cells
might be due to the leakiness.
FTH1 and transferrin receptor-1 (TfR-1) production are
tightlyregulatedbythelabileironpool(LIP)level[27].Thus,
FTH1 overexpression may increase the Fe storage and reduce
the LIP, which in turn leads to an upregulation of TfR-1. To
test whether FTH1 can induce this eﬀe c ti nN P CS 1 8c e l l s ,
the TfR-1 levels were measured in the repressed and de-
repressed state using Western blot assay (Figure 2(a)). A
statistically signiﬁcant increase, ∼56%, in the TfR-1 level was
observed in the de-repressed state as compared to that in the
repressed state.
FTH1 overexpression may trigger an increase in the
cell’s ability to internalize and store Fe. The relevance of6 Journal of Biomedicine and Biotechnology
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Figure 4: Eﬀects of FTH1 overexpression on cell proliferation in
other two clones. (a) FTH1 expression in diﬀerent cell clones was
measured by western blot assay. (b) Eﬀect of FTH1 overexpression
on cell proliferation. MTT assay was used to assess the eﬀect of
FTH1 overexpression on cell proliferation. Data were normalized
by those in parent cells without FAC supplementation. Data were
expressed as mean ± SD from 3 experiments. Parent cells grown in
absence of FAC were set as control. (∗P<0.001.)
intracellular iron content with the overexpression of FTH1
inresponsetoFACatdiﬀerentconcentrationswasconﬁrmed
by ICP-MS analysis. As shown in Figure 2(b),F A Cc a u s e da
dose-dependent increase of intracellular iron content. The
maximal intracellular iron content was achieved at 100∼
200μM FAC and further increase of FAC concentration did
not raise the intracellular iron content. At the same con-
centration of FAC (200μM), the intracellular iron content
was aﬀected by the FTH1 expression. When the doxycycline
concentration decreased from 10ng/mL to 0ng/mL, the iron
uptake increased due to a high FTH1 expression. These
results indicate that high FTH1 expression may increase the
iron uptake when the iron is available (Figure 2(c)).
3.2. Eﬀects of FTH1 Overexpression on Proliferation, Cytotox-
icity, Apoptosis, and Migration. B-7 clones could be main-
tained in the medium without doxycycline for up to two
months showing no evident toxicity. However, the clones
reached conﬂuence more rapidly in the presence of doxycy-
cline (10ng/mL) than that in absence, whereas doxycycline
at 10ng/mL had no evident eﬀects on B-7 cell growth.
To assess whether FTH1 transgene expression is detri-
mental to cell viability, methyl thiazole tetrazolium (MTT)
assay was used to measure the cellular proliferation
(Figure 3(a)). When cells were grown at 0.1ng/mL doxycy-
cline, moderate overexpression of FTH1 did not aﬀect cell
growth with or without Fe supplementation. While cells
were grown in absence of doxycycline, high expression of
FTH1haddiﬀerenteﬀects:thecellgrowthratewasdecreased
by 30% without Fe supplementation, but the growth rate
remained unchanged in the presence of Fe supplementation
when compared with that at the repressed state (10ng/mL
doxycycline). In other clones, cell growth at relatively high
level of FTH1 was independent of iron supplementation
(Figure 4). Ferritin level in these clones was much lower
relative to B-7 clone, and therefore, it is possible that
expression level was not high enough to aﬀect cell growth.
To further address the potential cytotoxicity of overex-
pression of FTH1, we detected the G6PD released into the
medium. No diﬀerence in the G6PD was found between
FTH1 overexpressed cells and FTH1-depressed cells regard-
less of iron supplementation (Figure 3(b)).
In addition, the eﬀect of FTH1 overexpression on the
apoptosis was also studied. Results showed no signiﬁcant
increase in the apoptosis of FTH1 over-expressed cells
as compared to FTH1 depressed cells regardless of iron
supplementation (Figure 3(c)).
The tumor metastasis has great impact on the recurrence
and prognosis of cancer in clinical practice. The NPC S18
cells are easy to migrate in vitro [24]. Whether FTH1
overexpression has inﬂuence on the tumor migration is
important for FTH1 as an MRI reporter. Thus, the eﬀect
of FTH1 overexpression on the migration of S18 cells in
vitrowas measured. As shown in Figure 3(d), overexpression
of FTH1 reduced the cell migration, which was reverse
following Fe supplementation.
3.3. Changes in Magnetic Relaxation Properties of B-7 Cells
In Vitro. T2-weighted images and transverse relaxation rates
(R2)o fB - 7c e l l su n d e rd i ﬀerent conditions are shown
in Figure 5. Results demonstrated a signiﬁcant increase
of R2 upon induction of FTH1 overexpression and iron
supplementation.Fesupplementationsigniﬁcantlyincreased
the R2, which reached the maximal level at 200μMF A Cb u t
further increase of FAC concentration did not additionally
increase the R2. At 0.1ng/mL doxycycline, the R2 was lower
than that in the absence of doxycycline, but higher than that
in presence of 10ng/mL doxycycline. These results indicate
both FTH1 expression and iron availability are important for
the induction of R2.
3.4. Iron Supplementation Enhanced MRI Signal and Reduced
the Aﬀection on Cell Growth of FTH1 In Vivo. To deter-
mine the changes in R2 relaxation rates relevant to FTH1
overexpression in vivo, B-7 cells and parent cells were
inoculated subcutaneously to BALB/c-nude mice. These
mice were administered with or without FAC in drinking
w a t e r( 2 go fF A Ci n1 Lo fw a t e r )[ 28]. All the mice
were not treated with doxycycline. As shown in Figures
6(a)–6(c), R2 was higher in B-7-cell-induced tumors than
that in parent-cell-induced tumors, and Fe supplementationJournal of Biomedicine and Biotechnology 7
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Figure 5: B-7 cells under both derepressed state (FTH1 overexpression) and the presence of FAC supplementation was capable of producing
visible contrast by MRI. (a) B-7 cells were cultured with or without 10ng/mL doxycycline and with or without FAC for T2-weighted images.
Arrow indicated the sample with the highest R2, in the presence of both FTH1 overexpression and iron supplementation (200μM) for 48h.
(b) B-7 cells were grown for 48h in the presence of FAC at diﬀerent concentrations. (c) B-7 cells grown in doxycycline (Dox) at diﬀerent
concentrations for 96h, and in 200μM FAC for 48h before analysis. Relaxation rates derived from the R2 maps were expressed as mean ±
SD for 3 experiments.
signiﬁcantly increased the R2 in B-7-cell-induced tumors
but no-in parent-cell-induced tumors. These results indicate
FTH1 overexpression can be detected by MRI and iron
supplementation speciﬁcally increases the eﬀect of FTH1 in
MRI in vivo.
We also examined whether FTH1 overexpression could
aﬀect the tumor progression in vivo. The tumors over-
expressing FTH1 with Fe supplementation grew in similar
ratewithparent-cell-inducedtumors.However,ascompared
to the parent-cell-induced tumors, the tumors overexpress-
ing FTH1 grew slower in the absence of Fe supplementation
(Figure 6(d)).
3.5. In Vivo and Ex Vivo Validation of Luciferase and FTH1
Expression. Subcutaneous B-7-cell-induced tumors and
parent cell tumors were examined by hematoxylin-eosin
(HE)staining, immunohistochemistry, andbioluminescence
imaging (BLI). In the HE staining (Figures 7(a) and 7(b)),
there was no detectable pathologic diﬀerences associated
with FTH1 overexpression and iron supplementation. As
expected, immunohistochemistry showed FTH1 overex-
pression was detectable in B-7-cell-induced tumors
(Figure 7(d)) but not in parent cell tumors (Figure 7(c)).
The luciferase activity in B-7-cell-induced tumors was
increased up to 106 photons/sec while that in parent cell8 Journal of Biomedicine and Biotechnology
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Figure 6: MRI of tumors over-expressing FTH1 in vivo. Representative T2-wighted images of mice with inoculation of B-7 cells (right) and
parent cells (left) were acquired at 21 days postinoculation without (a) or with (b) FAC supplementation in the drinking water. (c) R2 at
the tumor region. (d) Eﬀects of FTH1 overexpression on the tumor growth. B-7 cells and parent cells were inoculated into the hind ﬂank
of nude mice, and tumor volumes were measured from MR images at the indicated time points. Data were expressed as mean ± SD for 6
experiments. (∗P<0.05 and #P<0.01.)
tumors remained unchanged (Figure 7(e)). To evaluate the
impact of FTH1 overexpression on iron uptake, iron content
of both parent cell and B-7-cell-induced tumors were
quantiﬁed using ICP-MS (Figure 7(f)). Results indicated
that the iron content was higher in B-7 cell induced tumors
than in parent cell tumors, and FAC supplementation
promoted the iron uptake in B-7-cell-induced tumors, but
n o ti np a r e n tc e l lt u m o r s .
4. Discussion
In the present study, our results demonstrated that MRI
contrast due to FTH1 overexpression could be eﬀectively
detected and enhanced by iron supplementation in NPC S18
cells and xenografted tumors. These results were supported
by in vitro and in vivo ﬁndings that FTH1 overexpres-
sion signiﬁcantly increased the transverse relaxivities (R2),
whichwereenhancedbyironsupplementation.Additionally,
FTH1 overexpression led to some adverse eﬀects on the
proliferation and migration of S18 cells and the growth of
xenograftedtumors,andtheseeﬀectswereeliminatedbyiron
supplementation.
In previous studies, ﬁndings showed FTH1 overexpres-
sion could increase the R2 in C6 glioma cells [9], and stem
cells [16, 17], and iron supplementation could aﬀect the
MRI contrast [29, 30]. Through overexpression of FTH1 in
liver of transgenic mice (liver-hfer mice), Ziv et al. showed
that overexpression of FTH1 increased iron absorption and
elevated R2 values compared to wildtype, and iron-enrichedJournal of Biomedicine and Biotechnology 9
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Figure 7:Parentcells(aandc)andB-7cells(bandd)wereinoculatedintothehindﬂankofnudemice(left,parentcells;right,B-7cells)with
(FAC+)orwithout(FAC−)FACsupplementationinthedrinkingwater.Thetumorswerecollectedforhistologicalexaminationattheendof
3weeks.(aandb)HEstainingshowedoverexpressionofFTH1didnotcauseobviouspathologicalchanges.(candd)Immunohistochemistry
demonstrated overexpression of FTH1 was easily detected in B-7-cell-induced tumors but not in parent-cell-induced tumors. (e) Luciferase
activity detected by using bioluminescence imaging technology in vivo. Luciferase activity in B-7 cell induced tumors was increased up to
106 photons/sec, but that was not signiﬁcantly changed in the parent-cell-induced tumors as compared to the background activity (<300
photons/sec). Representative image from mice in the presence of FAC. (f) ICP-MS analysis of Fe content measured in parts per million
(ppm) dry weight of parent cells or B-7 cell induced tumors. Data were expressed as mean ± SD from 6 experiments. (∗P<0.05).
diet led to a signiﬁcant elevation in R2 values for both
wildtype and liver-hfer mice, but no signiﬁcant diﬀerence
between wildtype and liver-hfer mice. It maybe that the
hepatocyte itself was rich in iron [11], and the elevation
in R2 was not easily or signiﬁcantly detected. Wang et al.
showedthatinxenograftsderivedfromimplantedC6glioma
cells, overexpression of FTH1 induced a minimal contrast
in T2-weighted MRI images. Also in C6 glioma cells labeled
with SPIO (superparamagnetic iron oxide), overexpression
of FTH1 signiﬁcantly increased MRI contrast [30]. In the
present study, our results showed the FTH1 overexpression
in NPC S18 cells could signiﬁcantly increase the R2 and iron
supplementation could enhance the eﬃciency of FTH1. The
signals from T2 weight MR images acquired at 3.0T were
attenuated at the area of NPC xenografted tumors.
In our study, moderate overexpression of FTH1 in NPC
S18 cells in the presence of 0.1ng/mL doxycycline did not
aﬀect the cell growth with or without iron supplementation.
The maximum of FTH1 overexpression in the absence of
doxycycline reduced cell growth without iron supplementa-
tion but not in the presence of iron supplementation. These
results were in accordance with the study of Cozzi et al. [22],10 Journal of Biomedicine and Biotechnology
in which overexpression of FTH1 in Hela cells signiﬁcantly
reduced the cell growth, and this increase was reversed in
the presence of iron supplementation. Additionally, Liu et al.
[16] found that the growth of C6 glioma cells was reduced
signiﬁcantly when the FTH1 expression was dramatically
increased. Hempstead et al. revealed the overexpression
of mitochondrial ferritin dramatically reduced the growth
of implanted tumors in nude mice [31]. In the present
study, in other clones selected, clones with relatively high
FTH1 level had not reduced cell growth with or without
iron supplementation. This implies that remarkably high
expression of FTH1 can decrease cell growth in certain types
of cells.
Additionally, our results indicated signiﬁcantly high
expression of FTH1 reduced the migration of tumor cells
in the absence of iron supplementation. A moderate overex-
pression of FTH1 had no eﬀect on the migration of tumor
cells regardless of the iron supplementation. These results
implied that FTH1 overexpression could partially impair the
biological behaviors of NPC S18 cells.
In previous studies, the ﬁndings on the eﬀect of FTH1 on
cells were inconsistent. One study revealed FTH1 increases
the resistance to oxidative damage [22], but another showed
overexpression of FTH1 results in iron accumulation and
subsequent increase of reactive oxygen species [32]. Some
reports showed FTH1 overexpression has degenerative eﬀect
on neurons [33] and metabolism in the brain (by MRS) [34],
but others revealed FTH1 overexpression has no eﬀects on
theneurologicalsystem[34]andtheliver[35].Inthepresent
study, FTH1 overexpression did not increase reactive oxygen
species (indirectly indicated by G6PD release) and apoptosis.
Thus, the eﬀect of ferritin may depend on cell types, degree
of ferritin expression, and iron availability.
Overexpression of FTH1 causes transiently low level of
intracellular free iron and thus leads to physiological com-
pensation to augment iron uptake. Excessive intracellular
iron can be sequestered within the over-expressed FTH1
pool. Our results showed in the presence of iron supple-
mentation (100∼200μMF A Cin vitro; 2g/L in drinking
water), overexpression of FTH1 could increase R2 in vitro
and in vivo. Thus, we speculate that when the FTH1 is highly
over-expressed, more iron is needed to further enhance the
sensitivity of MRI. Additionally, the phenomenon that iron
supplementation can reverse the iron-deﬁcient phenotype
caused by FTH1 overexpression reminders us that, during
the application of FTH1 as an MRI reporter, Fe at appropri-
ate dose should be regularly administered during operation.
5. Conclusion
Our ﬁndings not only further support the eﬀectiveness of
FTH1 as an MRI reporter but also provide convincing
evidence on its safety in clinical application. The present
study elucidates that FTH1 can act eﬀectively and safely as
an MRI reporter with additional iron supplementation in
monitoringNPCinvitroandinvivo.Therefore,FTH1canbe
considered as promising MRI reporter in the NPC tracking.
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